Pages

Monday, April 21, 2025

Overview of Gout and It's Treatment

Overview of Gout

  • Gout: A form of inflammatory arthritis due to deposition of monosodium urate crystals.
  • Cause: Hyperuricemia (serum uric acid > 6.8 mg/dL)
  • Management goals:
    • Terminate acute attacks
    • Prevent future attacks
    • Lower serum uric acid levels

Classification of Anti-Gout Drugs

  1. Acute Attack Treatment:
    • Colchicine
    • NSAIDs
    • Corticosteroids
  2. Chronic Management:
    • Uricostatic agents (e.g., Allopurinol, Febuxostat)
    • Uricosuric agents (e.g., Probenecid, Sulfinpyrazone)

Allopurinol
  • Class: Xanthine oxidase inhibitor
  • Mechanism of Action:
    • Inhibits xanthine oxidase enzyme
    • Decreases production of uric acid
  • Indications:
    • Chronic gout
    • Prevention of uric acid nephropathy
    • Tumor lysis syndrome
  • Adverse Effects:
    • Rash (can be severe - SJS)
    • GI upset
    • Hepatotoxicity
    • Hypersensitivity syndrome
  • Drug Interactions:
    • Increases effect of azathioprine and 6-mercaptopurine
    • Requires dose reduction with these drugs

Febuxostat

  • Class: Selective xanthine oxidase inhibitor
  • Mechanism of Action:
    • Non-purine selective inhibitor of xanthine oxidase
    • Reduces serum uric acid
  • Indications:
    • Chronic hyperuricemia in gout
  • Adverse Effects:
    • Liver function abnormalities
    • Cardiovascular events (boxed warning)
    • Rash, nausea
  • Drug Interactions:
    • Same as allopurinol (azathioprine, mercaptopurine)

Colchicine

  • Class: Microtubule inhibitor
  • Mechanism of Action:
    • Binds tubulin, inhibits neutrophil motility and activity
    • Reduces inflammation in gouty arthritis
  • Indications:
    • Acute gout attacks
    • Gout prophylaxis
  • Adverse Effects:
    • GI upset (diarrhea, nausea, vomiting)
    • Myopathy and neuropathy (especially with renal impairment)
    • Bone marrow suppression (rare)
  • Drug Interactions:
    • CYP3A4 and P-gp inhibitors (e.g., clarithromycin, cyclosporine) increase toxicity

Probenecid

  • Class: Uricosuric agent
  • Mechanism of Action:
    • Inhibits reabsorption of uric acid in renal tubules
    • Increases urinary excretion of uric acid
  • Indications:
    • Chronic gout (underexcreters of uric acid)
  • Adverse Effects:
    • Uric acid kidney stones
    • GI irritation
    • Rash
  • Drug Interactions:
    • Inhibits excretion of many drugs (penicillin, NSAIDs)
    • Increases risk of toxicity

Sulfinpyrazone

  • Class: Uricosuric agent
  • Mechanism of Action:
    • Similar to probenecid
    • Promotes renal excretion of uric acid
  • Indications:
    • Chronic gout
  • Adverse Effects:
    • GI irritation
    • Rash
    • Agranulocytosis (rare)
  • Drug Interactions:
    • Displaces other drugs from plasma proteins
    • Inhibits metabolism of warfarin
Presentation for Drugs for Gout 


                                                                     END OF THE CHAPTER

No comments:

Post a Comment